Search Count: 30
 |
Structure Of Pfcsp Peptide 21 With Antibody Cis43_Var2
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2022-06-22 Classification: IMMUNE SYSTEM Ligands: SO4, GOL |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: SO4, GOL
 |
Structure Of Pfcsp Peptide 21 With Antibody Cis43_Var10
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-06-22 Classification: IMMUNE SYSTEM Ligands: GOL |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2022-06-22
Ligands: GOL
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M42.127
Organism: Homo sapiens, Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM/ANTIGEN Ligands: SO4 |
Organism: Homo sapiens, Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
Ligands: SO4
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M43.151
Organism: Homo sapiens, Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM/ANTIGEN |
Organism: Homo sapiens, Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Structure Of Pfcsp Peptide 21 With Antibody Igl-Cis43.D3
Organism: Homo sapiens, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM Ligands: MES, ZN |
Organism: Homo sapiens, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
Ligands: MES, ZN
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M43.160
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M42.126
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M43.149
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M43.159
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Crystal Structure Of Pfcsp Peptide 21 With Vaccine-Elicited Human Anti-Malaria Antibody M43.138
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2021-12-15 Classification: IMMUNE SYSTEM |
Organism: Mus musculus, Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2021-12-15
 |
Crystal Structure Of Computationally Designed Protein 3Ds18 In Complex With The Human Transferrin Receptor Ectodomain
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.47 Å Release Date: 2021-04-28 Classification: DE NOVO PROTEIN/METAL TRANSPORT Ligands: CA |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2021-04-28
Ligands: CA
 |
Crystal Structure Of Computationally Designed Protein 2Ds25.5 In Complex With The Human Transferrin Receptor Ectodomain
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.84 Å Release Date: 2021-04-28 Classification: DE NOVO PROTEIN Ligands: CA |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2021-04-28
Ligands: CA
 |
Crystal Structure Of Computationally Designed Protein 2Ds25.1 In Complex With The Human Transferrin Receptor Ectodomain
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:3.07 Å Release Date: 2021-04-28 Classification: DE NOVO PROTEIN/METAL TRANSPORT Ligands: CA, NAG, MAN |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2021-04-28
Ligands: CA, NAG, MAN
 |
R. Capsulatus Cyt Bc1 (Ciii2) At 3.3A
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: OXIDOREDUCTASE Ligands: FES, HEC |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: FES, HEC
 |
R. Capsulatus Cyt Bc1 With Both Fes Proteins In C Position (Ciii2 C-C)
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: HEC, FES |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: HEC, FES
 |
R. Capsulatus Cyt Bc1 With One Fes Protein In B Position And One In C Position (Ciii2 B-C)
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: FES, HEC |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: FES, HEC
 |
R. Capsulatus Cyt Bc1 With Both Fes Proteins In B Position (Ciii2 B-B)
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: HEC, FES |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: HEC, FES
 |
R. Capsulatus Ciii2Civ Bipartite Super-Complex (Sc-2A) With Ccoh/Cy
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: HEC, CU, FES |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: HEC, CU, FES
 |
R. Capsulatus Ciii2Civ Tripartite Super-Complex, Conformation A (Sc-1A)
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: FES, HEC, CU |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: FES, HEC, CU
 |
R. Capsulatus Ciii2Civ Tripartite Super-Complex, Conformation B (Sc-1B)
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY Release Date: 2020-12-30 Classification: TRANSLOCASE/Oxidoreductase Ligands: FES, HEC, CU |
Organism: Rhodobacter capsulatus (strain atcc baa-309 / nbrc 16581 / sb1003)
Method: ELECTRON MICROSCOPY
Release Date: 2020-12-30
Ligands: FES, HEC, CU